Sherbrooke and Eastern
Type of Organization
Field of Activity
Cancer / Oncology / Hematology
MethylGene Inc. is a publicly-traded, clinical stage, biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer.
MethylGene is a biopharmaceutical company with a mission to discover, develop and deliver new drugs to treat cancer. Our goal is to eventually market products that will improve the lives of patients suffering from this disease.
MethylGene develops drugs that specifically target enzymes that are involved in certain diseases such as cancer. We do this by understanding the characteristics of the enzyme involved in the disease and then creating a molecule that will specifically inhibit that enzyme from functioning. In this way, the enzyme may be controlled. Once we have a set of lead molecules, we have a seasoned biology team to then test our candidate drugs. Molecules that have the desired profile become clinical candidates and are eventually tested in human clinical trials.